tlooto
Sign up
MedicineBiology

The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.

Hye Mi Kim, Tejashree Joglekar, T. Cascone, Tullia C. Bruno

2026.6.18Nature Cancer

DOI: 10.1038/s43018-026-01188-1

Abstract

Abstract is not available.

Citation format

KIM, Hye Mi, et al. The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets. Nature Cancer, 2026.